Last updated on June 2019

Descriptive Observational Study ALK-2016-CPHG


Brief description of study

Descriptive Observational Study.

Characteristics Of ALK-positive and ROS1-positive Adults Patients Non-Small Cell Lung Cancer (NSCLC) Treated With Crizotinib Within General Hospitals

Detailed Study Description

Describe the characteristics of patients treated with crizotinib Describe efficacy, safety, observance and QoL.

Clinical Study Identifier: NCT03718117

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.